Our future journey is to bring strength to our organization, leaning on our unique pioneering heritage by bringing together BioTissue and Amniox, one company with one purpose and one vision. A single unified brand combining the unique power of both businesses.  BioTissue Surgical better reflects our vision as the regenerative medicine pioneer and our goals for the future as a biologic’s provider to realize the full potential of regenerative therapy.

We are BioTissue. The most human form of healing.

Neox® 1K is a cryopreserved ultra-thick human amniotic membrane derived from umbilical cord used as an adjunct treatment for chronic and acute, partial and full-thickness wounds.1,3-5 This allograft helps promote healing in complex diabetic foot ulcers complicated with osteomyelitis, comparing favorably to the Standard of Care.1,5,6 It’s up to 10 times thicker than amniotic membrane alone,7 which may increase longevity in the wound bed, potentially reducing applications and cost of care.

Neox 100 is a thinner cryopreserved version of our human amniotic membrane allograft, ideal for shallow wounds or for larger wound areas. The allograft is delivered on a non-implantable, gridded paper backing for easier handling and application.

Neox RT is a sterile, ultra-thick human amniotic membrane allograft derived from umbilical cord, for chronic and acute partial and full thickness wounds. Neox RT delivers the benefits of human amniotic allograft in a shelf stable product with room temperature storage. It is manufactured, using the SteriTek® preservation process, stored in saline (0.9% w/v NaCl)and terminally sterilized via gamma irradiation yielding a hydrated shelf stable product.